Tuesday, 28 December 2010

Cyclandelate




In the US, Cyclandelate (cyclandelate systemic) is a member of the drug class peripheral vasodilators and is used to treat Nocturnal Leg Cramps, Raynaud's Syndrome and Renal Artery Atherosclerosis.

US matches:

  • Cyclandelate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C04AX01

CAS registry number (Chemical Abstracts Service)

0000456-59-7

Chemical Formula

C17-H24-O3

Molecular Weight

276

Therapeutic Category

Vasodilator, peripheric

Chemical Name

Benzeneacetic acid, α-hydroxy-, 3,3,5-trimethylcyclohexyl ester

Foreign Names

  • Cyclandelatum (Latin)
  • Cyclandelat (German)
  • Cyclandélate (French)
  • Ciclandelato (Spanish)

Generic Names

  • Ciclandelato (OS: DCIT)
  • Cyclandelate (OS: BAN, JAN)
  • Cyclandélate (OS: DCF)
  • BS 572 (IS)
  • Cyclandelate (PH: USP 32, JP VIII)

Brand Names

  • Cyclandelat Streuli
    Streuli Pharma, Switzerland


  • Cyclospasmol
    Yamanouchi, Luxembourg


  • Vesselon
    New Chem & Pharm, Taiwan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 23 December 2010

Nitrolong




Nitrolong may be available in the countries listed below.


Ingredient matches for Nitrolong



Pentaerithrityl Tetranitrate

Pentaerithrityl Tetranitrate is reported as an ingredient of Nitrolong in the following countries:


  • Georgia

International Drug Name Search

Wednesday, 22 December 2010

Urso


See also: Generic Urso Forte


Urso is a brand name of ursodiol, approved by the FDA in the following formulation(s):


URSO 250 (ursodiol - tablet; oral)



  • Manufacturer: APTALIS PHARMA US

    Approval date: December 10, 1997

    Strength(s): 250MG [AB]

Has a generic version of Urso been approved?


Yes. The following products are equivalent to Urso:


ursodiol tablet; oral



  • Manufacturer: GLENMARK GENERICS

    Approval date: July 12, 2011

    Strength(s): 250MG [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: May 13, 2009

    Strength(s): 250MG [AB]


  • Manufacturer: WATSON LABS INC

    Approval date: December 23, 2011

    Strength(s): 250MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Urso. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Urso.

See also...

  • Urso Consumer Information (Wolters Kluwer)
  • Urso Consumer Information (Cerner Multum)
  • Urso Advanced Consumer Information (Micromedex)
  • Urso 250 Advanced Consumer Information (Micromedex)
  • Ursodiol Consumer Information (Wolters Kluwer)
  • Ursodiol Consumer Information (Cerner Multum)
  • Ursodiol Advanced Consumer Information (Micromedex)
  • Ursodiol AHFS DI Monographs (ASHP)

Thursday, 16 December 2010

Istodax


Istodax is a brand name of romidepsin, approved by the FDA in the following formulation(s):


ISTODAX (romidepsin - powder; iv (infusion))



  • Manufacturer: CELGENE

    Approval date: November 5, 2009

    Strength(s): 10MG/VIAL [RLD]

Has a generic version of Istodax been approved?


No. There is currently no therapeutically equivalent version of Istodax available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Istodax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • FR901228 substance and preparation thereof
    Patent 4,977,138
    Issued: December 11, 1990
    Inventor(s): Okuhara; Masakuni & Goto; Toshio & Hori; Yasuhiro & Fujita; Takashi & Ueda; Hirotsugu & Shigematsu; Nobuharu
    Assignee(s): Fujisawa Pharmaceutical Co., Ltd.
    The invention relates to a compound having antimicrobial and antitumor activity, the compound being designated FR901228 substance of the following formula: ##STR1##
    Patent expiration dates:

    • July 6, 2012
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Method of producing FR901228
    Patent 7,608,280
    Issued: October 27, 2009
    Inventor(s): Ueda; Satoshi & Watamoto; Yoko & Tsuboi; Masaru & Kanda; Munekazu & Higaki; Tomoji & Matsuda; Mitsunori
    Assignee(s): Astellas Pharma Inc.
    Depsipeptides and congeners thereof are disclosed having structure (I), wherein m, n, p, q, X, R1, R2 and R3 are as defined herein. These compounds, including FR901228, have activity as, for example, immunosuppressants, as well as for the prevention or treatment of patients suffering or at risk of suffering from inflammatory, autoimmune or immune system-related diseases including graft-versus-host disease and enhancement of graft/tissue survival following transplant. Also provided are methods for inhibiting lymphocyte activation, proliferation, and/or suppression of IL-2 secretion. Also provided are crystalline forms of FR901228, e.g., type A and type B crystalline forms of FR901228.
    Patent expiration dates:

    • August 22, 2021
      ✓ 
      Drug substance




  • Method of producing FR901228
    Patent 7,611,724
    Issued: November 3, 2009
    Inventor(s): Ueda; Satoshi & Watamoto; Yoko & Tsuboi; Masaru & Kanda; Munekazu & Higaki; Tomoji & Matsuda; Mitsunori
    Assignee(s): Astellas Pharma Inc.
    Depsipeptides and congeners thereof are disclosed having structure (I), wherein m, n, p, q, X, R1, R2 and R3 are as defined herein. These compounds, including FR901228, have activity as, for example, immunosuppressants, as well as for the prevention or treatment of patients suffering or at risk of suffering from inflammatory, autoimmune or immune system-related diseases including graft-versus-host disease and enhancement of graft/tissue survival following transplant. Also provided are methods for inhibiting lymphocyte activation, proliferation, and/or suppression of IL-2 secretion. Also provided are crystalline forms of FR901228, e.g., type A and type B crystalline forms of FR901228.
    Patent expiration dates:

    • August 22, 2021
      ✓ 
      Drug substance



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • November 5, 2014 - NEW CHEMICAL ENTITY

    • November 5, 2016 - ORPHAN DRUG EXCLUSIVITY

    • June 16, 2018 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Istodax Consumer Information (Drugs.com)
  • Istodax Consumer Information (Wolters Kluwer)
  • Istodax Consumer Information (Cerner Multum)
  • Istodax Advanced Consumer Information (Micromedex)
  • Istodax AHFS DI Monographs (ASHP)
  • Romidepsin Consumer Information (Wolters Kluwer)
  • Romidepsin Consumer Information (Cerner Multum)
  • Romidepsin Intravenous Advanced Consumer Information (Micromedex)
  • Romidepsin AHFS DI Monographs (ASHP)

Monday, 13 December 2010

Bambudil




Bambudil may be available in the countries listed below.


Ingredient matches for Bambudil



Bambuterol

Bambuterol hydrochloride (a derivative of Bambuterol) is reported as an ingredient of Bambudil in the following countries:


  • India

  • Sri Lanka

International Drug Name Search

Monday, 6 December 2010

Vicenrik




Vicenrik may be available in the countries listed below.


Ingredient matches for Vicenrik



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vicenrik in the following countries:


  • Argentina

International Drug Name Search

Thursday, 2 December 2010

Megadose




Megadose may be available in the countries listed below.


Ingredient matches for Megadose



Dopamine

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Megadose in the following countries:


  • Argentina

International Drug Name Search

Saturday, 27 November 2010

Aspinal




Aspinal may be available in the countries listed below.


Ingredient matches for Aspinal



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Aspinal in the following countries:


  • Turkey

International Drug Name Search

Friday, 26 November 2010

Interferone beta




Interferone beta may be available in the countries listed below.


Ingredient matches for Interferone beta



Interferon beta

Interferone beta (DCIT) is also known as Interferon beta (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 24 November 2010

Lidokain




Lidokain may be available in the countries listed below.


Ingredient matches for Lidokain



Lidocaine

Lidocaine is reported as an ingredient of Lidokain in the following countries:


  • Croatia (Hrvatska)

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Lidokain in the following countries:


  • Bosnia & Herzegowina

  • Croatia (Hrvatska)

  • Serbia

  • Slovenia

International Drug Name Search

Tuesday, 23 November 2010

Lipohep




Lipohep may be available in the countries listed below.


Ingredient matches for Lipohep



Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Lipohep in the following countries:


  • Poland

International Drug Name Search

Sunday, 21 November 2010

Bivol




Bivol may be available in the countries listed below.


Ingredient matches for Bivol



Nebivolol

Nebivolol hydrochloride (a derivative of Nebivolol) is reported as an ingredient of Bivol in the following countries:


  • Greece

International Drug Name Search

Saturday, 20 November 2010

Azotesin




Azotesin may be available in the countries listed below.


Ingredient matches for Azotesin



Sodium Gualenate

Sodium Gualenate is reported as an ingredient of Azotesin in the following countries:


  • Japan

International Drug Name Search

Tuesday, 16 November 2010

Flutinasal




Flutinasal may be available in the countries listed below.


Ingredient matches for Flutinasal



Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Flutinasal in the following countries:


  • Greece

International Drug Name Search

Saturday, 13 November 2010

Gen-Lamotrigine




Gen-Lamotrigine may be available in the countries listed below.


Ingredient matches for Gen-Lamotrigine



Lamotrigine

Lamotrigine is reported as an ingredient of Gen-Lamotrigine in the following countries:


  • Canada

International Drug Name Search

Wednesday, 10 November 2010

Acellin




Acellin may be available in the countries listed below.


Ingredient matches for Acellin



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Acellin in the following countries:


  • Germany

International Drug Name Search

Monday, 8 November 2010

Coldrex Laryplus




Coldrex Laryplus may be available in the countries listed below.


Ingredient matches for Coldrex Laryplus



Benzyl Alcohol

Benzyl Alcohol 2,4-Dichloro- (a derivative of Benzyl Alcohol) is reported as an ingredient of Coldrex Laryplus in the following countries:


  • Slovenia

Hexylresorcinol

Hexylresorcinol is reported as an ingredient of Coldrex Laryplus in the following countries:


  • Slovenia

International Drug Name Search

Saturday, 6 November 2010

Kodein Dak




Kodein Dak may be available in the countries listed below.


Ingredient matches for Kodein Dak



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Kodein Dak in the following countries:


  • Denmark

International Drug Name Search

Friday, 5 November 2010

Picedin




Picedin may be available in the countries listed below.


Ingredient matches for Picedin



Piracetam

Piracetam is reported as an ingredient of Picedin in the following countries:


  • Taiwan

International Drug Name Search

Atenolol and Chlorthalidone




Ingredient matches for Atenolol and Chlorthalidone



Atenolol

Atenolol is reported as an ingredient of Atenolol and Chlorthalidone in the following countries:


  • United States

Chlortalidone

Chlortalidone is reported as an ingredient of Atenolol and Chlorthalidone in the following countries:


  • United States

International Drug Name Search

Tuesday, 2 November 2010

Transact




Transact may be available in the countries listed below.


Ingredient matches for Transact



Flurbiprofen

Flurbiprofen is reported as an ingredient of Transact in the following countries:


  • South Africa

International Drug Name Search

Wednesday, 27 October 2010

Difenidol




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000972-02-1

Chemical Formula

C21-H27-N-O

Molecular Weight

309

Therapeutic Category

Antiemetic

Chemical Name

1-Piperidinebutanol, α,α-diphenyl-

Foreign Names

  • Difenidolum (Latin)
  • Difenidol (German)
  • Difénidol (French)
  • Difenidol (Spanish)

Generic Names

  • Difenidol (OS: BAN)
  • Diphenidol (OS: USAN, BAN)
  • SKF 478 (IS)
  • Difenidol Hydrochloride (OS: JAN)
  • Diphenidol Hydrochloride (OS: USAN)
  • SKF 478-A (IS)
  • Difenidol Hydrochloride (PH: JP XV)

Brand Names

  • Difenidol Laida Pharm
    Laida, China


  • Cedol
    Pei Li, Taiwan


  • Cephadol
    Nippon Shinyaku, Japan; Nippon Shinyaku, Taiwan


  • Deanosarl
    Isei, Japan


  • Difenidolin
    Taiyo Pharmaceutical, Japan


  • Dinidol
    Standard, Taiwan


  • Diphenidol
    Hua Shin, Taiwan; Standard, Taiwan


  • Isodadol
    Taisho Yakuhin, Japan


  • Keidole
    Sankei Yakuhin, Japan


  • Mecalmin
    Choseido Pharmaceutical, Japan


  • Pineroro
    Maruko Seiyaku, Japan


  • Satanolon
    Tatsumi Kagaku, Japan


  • Shulander
    Tsuruhara Seiyaku, Japan


  • Sobulaline
    Kotobuki Seiyaku, Japan


  • Tosperal
    Towa Yakuhin, Japan


  • Vontrol
    GlaxoSmithKline, Chile; GlaxoSmithKline, El Salvador; GlaxoSmithKline, United States; Sanfer, Mexico


  • Voxamine
    Armstrong, Mexico


  • Wansar
    Mylan Pharmaceutical, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 25 October 2010

Yatrox




Yatrox may be available in the countries listed below.


Ingredient matches for Yatrox



Ondansetron

Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Yatrox in the following countries:


  • Peru

  • Spain

International Drug Name Search

Thursday, 21 October 2010

Clinda-Derm




In the US, Clinda-Derm (clindamycin topical) is a member of the drug class topical acne agents and is used to treat Acne and Perioral Dermatitis.

US matches:

  • Clinda-Derm Topical

  • Clinda-Derm

Ingredient matches for Clinda-Derm



Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Clinda-Derm in the following countries:


  • United States

International Drug Name Search

Wednesday, 20 October 2010

Gouty Nephropathy Medications


There are currently no drugs listed for "Gouty Nephropathy".

Learn more about Gouty Nephropathy





Drug List:

Monday, 18 October 2010

Adco-Bisocor




Adco-Bisocor may be available in the countries listed below.


Ingredient matches for Adco-Bisocor



Bisoprolol

Bisoprolol is reported as an ingredient of Adco-Bisocor in the following countries:


  • South Africa

International Drug Name Search

Sunday, 17 October 2010

Cumarol




Cumarol may be available in the countries listed below.


Ingredient matches for Cumarol



Acenocoumarol

Acenocoumarol is reported as an ingredient of Cumarol in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 13 October 2010

Frovamig




Frovamig may be available in the countries listed below.


Ingredient matches for Frovamig



Frovatriptan

Frovatriptan is reported as an ingredient of Frovamig in the following countries:


  • Estonia

  • Latvia

  • Lithuania

Frovatriptan succinate monohydrate (a derivative of Frovatriptan) is reported as an ingredient of Frovamig in the following countries:


  • Austria

International Drug Name Search

Friday, 1 October 2010

Coltoux




Coltoux may be available in the countries listed below.


Ingredient matches for Coltoux



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Coltoux in the following countries:


  • Vietnam

International Drug Name Search

Saturday, 25 September 2010

Vagomine




Vagomine may be available in the countries listed below.


Ingredient matches for Vagomine



Dimenhydrinate

Dimenhydrinate is reported as an ingredient of Vagomine in the following countries:


  • Luxembourg

International Drug Name Search

Thursday, 23 September 2010

Xapro




Xapro may be available in the countries listed below.


Ingredient matches for Xapro



Estriol

Estriol is reported as an ingredient of Xapro in the following countries:


  • Germany

International Drug Name Search

Monday, 20 September 2010

Trymo




In the US, Trymo is a member of the drug class H. pylori eradication agents.

Ingredient matches for Trymo



Bismuthate, Tripotassium Dicitrato-

Bismuthate, Tripotassium Dicitrato- is reported as an ingredient of Trymo in the following countries:


  • India

International Drug Name Search

Sulfaclozine




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0027890-59-1

Chemical Formula

C10-H9-Cl-N4-O2-S

Molecular Weight

284

Therapeutic Categories

Antibacterial: Sulfonamid

Antiprotozoal: Agent against coccidiosis

Chemical Name

N-(6-Chloropyrazinyl)sulfanilamide

Foreign Names

  • Sulfaclozinum (Latin)
  • Sulfaclozin (German)
  • Sulfaclozine (French)
  • Sulfaclozina (Spanish)

Generic Name

  • Sulfachlorpyrazin (IS)

Brand Names

  • Sulfacloropirazina (veterinary use)
    Chemifarma, Italy


  • ESB (veterinary use)
    Fort Dodge Animale Health, United States; Novartis Animal Health, Luxembourg; Novartis Animal Health, Netherlands; Novartis Animal Health, South Africa; Novartis Farma -Produtos Farmaceuticos S.A., Portugal; Novartis Tiergesundheit, Switzerland


  • Esbetre (veterinary use)
    Novartis Animal Health, Sweden


  • Sodium Sulfachloropyrazine (veterinary use)
    Fort Dodge Animale Health, United States

International Drug Name Search

Glossary

ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 13 September 2010

Medroxyprogesterone




In some countries, this medicine may only be approved for veterinary use.


In the US, Medroxyprogesterone (medroxyprogesterone systemic) is a member of the following drug classes: contraceptives, hormones/antineoplastics, progestins and is used to treat Abnormal Uterine Bleeding, Amenorrhea, Birth Control, Endometrial Cancer, Endometrial Hyperplasia - Prophylaxis, Endometriosis and Renal Cell Carcinoma.

US matches:

  • Medroxyprogesterone

  • Medroxyprogesterone Injectable Suspension

  • Medroxyprogesterone Injectable Suspension (Subcutaneous)

  • Medroxyprogesterone injectable

  • Medroxyprogesterone Intramuscular

  • Medroxyprogesterone Acetate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G03AC06,G03DA02,L02AB02

CAS registry number (Chemical Abstracts Service)

0000520-85-4

Chemical Formula

C22-H32-O3

Molecular Weight

344

Therapeutic Categories

Progestin

Antineoplastic agent

Chemical Name

Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6α)-

Foreign Names

  • Medroxyprogesteronum (Latin)
  • Medroxyprogesteron (German)
  • Médroxyprogestérone (French)
  • Medroxiprogesterona (Spanish)

Generic Names

  • Medrossiprogesterone (OS: DCIT)
  • Medroxyprogesterone (OS: BAN)
  • Médroxyprogestérone (OS: DCF)
  • Medroxyprogesterone Acetate (OS: BANM, JAN)
  • Methylhydroxyprogesterone acetate (IS)
  • Methypregnone (IS)
  • Metigesterona (IS)
  • Medroxyprogesteronacetat (PH: Ph. Eur. 6)
  • Médroxyprogestérone (acétate de) (PH: Ph. Eur. 6)
  • Medroxyprogesterone Acetate (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
  • Medroxyprogesteroni acetas (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Contracep
    Gomtal, Peru


  • Dépo-Prodasone
    Pfizer, Tunisia


  • Divina (Medroxyprogesterone and Estradiol)
    Abdi Ibrahim, Turkey; Innotech, Tunisia; Orion, Hungary


  • Diviseq (Medroxyprogesterone and Estradiol)
    Orion, Switzerland; Orion, Taiwan


  • Farlutal Inyectable
    Pfizer, Chile


  • Femihexal
    Hexal, Czech Republic


  • Medroxiprogesterona Induquimica
    Induquimica, Peru


  • Medroxiprogesterona Pfizer
    Pfizer, Peru


  • Megestron
    Organon, Peru


  • Progestagen
    Ethical, Dominican Republic


  • Provera
    Pfizer, Latvia; Techno, Bangladesh


  • Roxyprog
    Pak, Peru


  • Triaval (Medroxyprogesterone and Estradiol 17ß-valerate)
    Orion, Switzerland


  • Anoesterine (veterinary use)
    Dopharma, Netherlands


  • Anovulin (veterinary use)
    Ceva, Netherlands


  • Anovutab (veterinary use)
    Ceva, Netherlands


  • Apo-Medroxy
    Apotex, Canada


  • Aragest
    Dexxon, Israel


  • Ciclotal
    Lemery, Peru


  • Climanor
    Resource, United Kingdom


  • Climaterol HT (Medroxyprogesterone and Estrogens, conjugated)
    GYNOpharm, Colombia


  • Climatrol HT Continuo (Medroxyprogesterone and Estrogens, conjugated)
    Gynopharm, Peru


  • Climopax (Medroxyprogesterone and Estrogens, conjugated)
    Wyeth, Germany


  • Colircusi Medrivas (Medroxyprogesterone and Tetryzoline)
    Alcon, Spain


  • Controlestril (veterinary use)
    Omega Pharma France, France


  • Cyclofemina (Medroxyprogesterone and Estradiol 17ß-cypionate:)
    ABL, Peru


  • Depo Promone (veterinary use)
    Pfizer, Poland; Pfizer Animal Health, Luxembourg; Pfizer Santé Animale, France


  • Depo-Clinovir
    Pfizer, Germany


  • Depocon
    Pfizer, Austria


  • Depogeston (veterinary use)
    Biowet Pulawy, Poland


  • Depo-Prodasone
    Pfizer, Chile


  • Dépo-Prodasone
    Pfizer, France


  • Depo-Progevera
    Pfizer, Spain


  • Depo-Promone (veterinary use)
    Pfizer Animal Health, Belgium; Pfizer Animal Health, Switzerland; Pfizer Animal Health, Netherlands


  • Depo-Provera
    Delphi, Netherlands; Eczacibasi, Turkey; Euro, Netherlands; Pfizer, Australia; Pfizer, Belgium; Pfizer, Bahrain; Pfizer, Brazil; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Colombia; Pfizer, Czech Republic; Pfizer, Denmark; Pfizer, Ecuador; Pfizer, Estonia; Pfizer, Finland; Pfizer, United Kingdom; Pfizer, Georgia; Pfizer, Hong Kong; Pfizer, Hungary; Pfizer, Ireland; Pfizer, Israel; Pfizer, India; Pfizer, Iceland; Pfizer, Italy; Pfizer, Lithuania; Pfizer, Luxembourg; Pfizer, Luxembourg; Pfizer, Latvia; Pfizer, Malaysia; Pfizer, Netherlands; Pfizer, Norway; Pfizer, New Zealand; Pfizer, Oman; Pfizer, Peru; Pfizer, Philippines; Pfizer, Poland; Pfizer, Portugal; Pfizer, Sweden; Pfizer, Singapore; Pfizer, United States; Pfizer, Venezuela; Pfizer, Vietnam; Pfizer, South Africa; Pharmacia, Bangladesh; Pharmacia, Greece; Pharmacia, Romania; Upjohn, Ethiopia


  • Dépo-Provera
    Pfizer, France


  • Depo-Provera (veterinary use)
    Pfizer Animal Health, Finland


  • Depo-Ralovera
    Pfizer, Australia


  • Depo-SubQ Provera
    Pfizer, United States


  • Depotrust
    Umeda, Philippines


  • Divina (Medroxyprogesterone and Estradiol)
    HRA, France; Organon, Greece; Orion, Poland; Orion, Slovakia


  • Divina Paranova (Medroxyprogesterone and Estradiol)
    Orion, Denmark


  • Divina Plus (Medroxyprogesterone and Estradiol)
    Orion, Denmark; Orion, Sweden


  • Diviplus (Medroxyprogesterone and Estradiol)
    Eumedica, Belgium


  • Diviseg (Medroxyprogesterone and Estradiol)
    Orion, Slovakia


  • Diviseq (Medroxyprogesterone and Estradiol)
    Orion, Poland; Orion, Thailand


  • Diviva (Medroxyprogesterone and Estradiol)
    Eumedica, Belgium


  • Dugen
    Hemofarm, Serbia


  • Duova (Medroxyprogesterone and Estradiol 17ß-valerate)
    HRA, France


  • Enaf
    Umeda, Thailand


  • Estopause (Medroxyprogesterone and Estradiol)
    Faran Laboratories, Greece


  • Estranova C.C. (Medroxyprogesterone and Estradiol)
    ABL, Peru


  • Farlutal Depot
    Deva, Turkey; Pfizer, Austria


  • Farlutal
    Deva, Turkey; IFET, Greece; Pfizer, Austria; Pfizer, Belgium; Pfizer, Brazil; Pfizer, Switzerland; Pfizer, Chile; Pfizer, Estonia; Pfizer, Spain; Pfizer, Finland; Pfizer, France; Pfizer, Italy; Pfizer, Luxembourg; Pfizer, Norway; Pfizer, Oman; Pfizer, Singapore; Pfizer, Thailand; Pfizer, Taiwan; Pfizer, Vietnam; Pharmacia, Bulgaria; Pharmacia, Bahrain; Pharmacia, Luxembourg; Pharmacia, Romania


  • Farlutale
    Pfizer, Argentina


  • Filena (Medroxyprogesterone and Estradiol)
    Organon, Italy


  • Gen-Medroxy
    Genpharm, Canada


  • Gestapuran
    Leo, Finland


  • Gestomikron
    Adamed, Poland


  • Gynécalm (veterinary use)
    Virbac, France


  • Hebdo'pil (veterinary use)
    Omega Pharma France, France


  • Hexal-Mpa
    Hexal, South Africa


  • Hysron
    Kyowa Hakko Kirin, Japan


  • Hysron H
    Kyowa Hakko Kirin, Japan


  • Indivina (Medroxyprogesterone and Estradiol)
    Orion, Switzerland; Orion, Germany; Orion, Denmark; Orion, United Kingdom; Orion, Hungary; Orion, Lithuania; Orion, Norway; Orion, Sweden; Orion, Slovakia; Orion, Thailand; Orion, Taiwan


  • Livomedrox
    Varifarma, Argentina


  • Lunelle (Medroxyprogesterone and Estradiol Cypionate)
    Pfizer, United States


  • Lyndavel
    Umeda, Philippines


  • Medkiron
    Towa Yakuhin, Japan


  • Medroplex
    Teva, Czech Republic


  • Medrosterona
    Gador, Argentina


  • Medroxiprogesteron Acetat
    Terapia, Romania


  • Medroxiprogesterona Acetato L.CH.
    Chile, Chile


  • Medroxiprogesterona Filaxis
    Filaxis, Argentina


  • Medroxiprogesterona
    LKM, Argentina


  • Medroxoral (veterinary use)
    A.S.T. farma B.V, Netherlands


  • Medroxyhexal
    Sandoz, Australia


  • Medroxyprogesteron (veterinary use)
    Alfasan, Netherlands


  • Medroxyprogesteronacetaat PCH
    Pharmachemie, Netherlands


  • Medroxyprogesteron-Acetaat
    IFET, Greece


  • Medroxyprogesterone Acetate
    Duramed, United States; Greenstone, United States; Major, United States; Sandoz, United States; Sicor, United States; Teva USA, United States; USL Pharma, United States


  • Megestron
    Organon, Colombia; Organon, Ghana; Organon, Kenya; Organon, Mexico; Organon, Netherlands; Organon, Romania; Organon, Serbia; Organon, Tanzania; Organon, Zimbabwe; Organon Teknika, Ethiopia


  • Mepastat
    Orion, Finland


  • Meprate
    Serum Institute, India


  • Mepro
    Johnson, Taiwan


  • MPA GYN
    Hexal, Germany


  • MPA Hexal
    Hexal, Germany; Hexal, Luxembourg


  • MPA (veterinary use)
    Ilium Veterinary Products, Australia


  • MPA-beta
    Betapharm, Germany


  • Nadigest (veterinary use)
    Streuli Vet, Switzerland


  • Nerfin
    Pola Pharma, Japan


  • Non-Preg
    LBS Laboratory, Myanmar


  • Oestro Tabs Plus cyclic (Medroxyprogesterone and Estradiol)
    Vifor, Switzerland


  • Osmil (Medroxyprogesterone and Estradiol)
    Opfermann, Germany


  • Ovucon (veterinary use)
    Intervet, Netherlands


  • Perifem (Medroxyprogesterone and Estradiol)
    Organon, Spain


  • Perlutex
    Leo, Bangladesh; Leo, Dominican Republic; Leo, Guatemala; Leo, Honduras; Leo, Iceland; Leo, Norway; Leo, Panama; Leo, El Salvador; LEO Pharma, Denmark


  • Perlutex (veterinary use)
    Bayer Animal, Germany; Bayer Sanità Animale, Italy; Dechra, Netherlands; Dechra Veterinary Products, France; Gräub, Switzerland; Leo, United Kingdom; Leo, Ireland; Leo Pharma Animal, Norway; Leo Vet, Portugal; VetXX, Austria; VetXX, Finland; VetXX, Sweden


  • Petogen
    BodenPTY Limited Trading, Ethiopia; Kope Trading, Peru


  • Petogen-Fresenius
    Bodene, South Africa


  • Planibu
    Fahrenheit, Indonesia


  • Premelle (Medroxyprogesterone and Estrogens, conjugated)
    Wyeth, Oman; Wyeth, South Africa


  • Premia (Medroxyprogesterone and Estrogens, conjugated)
    Wyeth, Australia; Wyeth, New Zealand


  • Premique (Medroxyprogesterone and Conjugated estrogens)
    Wyeth, Malta; Wyeth Pharmaceuticals, United Kingdom


  • Premphase (Medroxyprogesterone and Estrogens, conjugated)
    Wyeth, United States


  • Premplus (Medroxyprogesterone and Estrogens, conjugated)
    Wyeth, Canada


  • Prempro (Medroxyprogesterone and Estrogens, conjugated)
    Wyeth, United States


  • Procadog (veterinary use)
    Femada, Switzerland


  • Prodafem
    Pfizer, Austria; Pfizer, Switzerland


  • Prodasone
    Pfizer, Chile


  • Progeron
    Remedica, Cyprus


  • Progeston
    Fuji Yakuhin, Japan


  • Progevera
    Pfizer, Spain


  • Promon (veterinary use)
    Boehringer Ingelheim, Sweden; Boehringer Ingelheim Vet, Norway


  • Promone-E (veterinary use)
    Pharmacia, Ireland; Pharmacia Animal Health, United Kingdom


  • Provera
    Grünenthal, Mexico; Pfizer, Australia; Pfizer, Belgium; Pfizer, Brazil; Pfizer, Belize; Pfizer, Canada; Pfizer, Chile; Pfizer, Colombia; Pfizer, Costa Rica; Pfizer, Czech Republic; Pfizer, Denmark; Pfizer, Ecuador; Pfizer, Estonia; Pfizer, Finland; Pfizer, United Kingdom; Pfizer, Georgia; Pfizer, Guatemala; Pfizer, Hong Kong; Pfizer, Honduras; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Indonesia; Pfizer, Ireland; Pfizer, Israel; Pfizer, Italy; Pfizer, Japan; Pfizer, Lithuania; Pfizer, Luxembourg; Pfizer, Malaysia; Pfizer, Nicaragua; Pfizer, Netherlands; Pfizer, Norway; Pfizer, New Zealand; Pfizer, Panama; Pfizer, Peru; Pfizer, Philippines; Pfizer, Poland; Pfizer, Portugal; Pfizer, Sweden; Pfizer, Singapore; Pfizer, El Salvador; Pfizer, Thailand; Pfizer, Taiwan; Pfizer, United States; Pfizer, Venezuela; Pfizer, Vietnam; Pfizer, South Africa; Pharmacia, Ghana; Pharmacia, Kenya; Pharmacia, Liberia; Pharmacia, Luxembourg; Pharmacia, Slovakia; Pharmacia, Sierra Leone; Pharmacia, Tanzania; Pharmacia, Uganda; Pharmacia, Zimbabwe; Pharmacia & Upjohn, Slovenia; Pharmacia & Upjohn, Slovakia; Pharmacia Upjohn, Oman; Upjohn, Ethiopia


  • Provera (veterinary use)
    Pfizer Animal Health, Netherlands


  • Ralovera
    Pfizer, Australia


  • Sayana
    Pfizer, Austria; Pfizer, Germany


  • Sedometril (veterinary use)
    Albrecht, Germany


  • Sisare (Medroxyprogesterone and Estradiol)
    Essex, Germany


  • Supprestral (veterinary use)
    Laboratoire Vétoquinol, France; Selecta, Germany; Stricker, Switzerland; Vetoquinol, Belgium; Vetoquinol, Luxembourg; Vetoquinol, Netherlands


  • Synchron Sponge (veterinary use)
    Eurovet, Netherlands


  • Trevina (Medroxyprogesterone and Estradiol)
    Orion, Denmark


  • Tridestra (Medroxyprogesterone and Estradiol)
    Orion, United Kingdom


  • Trivina (Medroxyprogesterone and Estradiol)
    Aspen Pharmacare, South Africa; Orion, Sweden


  • Veramix (veterinary use)
    Pfizer Animal Health, Netherlands; Pharmacia, Ireland; Pharmacia, Luxembourg; Pharmacia Animal Health, United Kingdom


  • Veraplex
    Combiphar, Indonesia; Pharmachemie, Indonesia; Pharmachemie, Malaysia; Pharmachemie, Peru; Teva, Argentina; Teva, Belgium; Teva, Latvia

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 9 September 2010

Hemocuron




Hemocuron may be available in the countries listed below.


Ingredient matches for Hemocuron



Tribenoside

Tribenoside is reported as an ingredient of Hemocuron in the following countries:


  • Japan

International Drug Name Search

Tuesday, 31 August 2010

Cloxicap




Cloxicap may be available in the countries listed below.


Ingredient matches for Cloxicap



Cloxacillin

Cloxacillin sodium salt (a derivative of Cloxacillin) is reported as an ingredient of Cloxicap in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 22 August 2010

Ostidil-D3




Ostidil-D3 may be available in the countries listed below.


Ingredient matches for Ostidil-D3



Alfacalcidol

Alfacalcidol is reported as an ingredient of Ostidil-D3 in the following countries:


  • Italy

International Drug Name Search

Saturday, 14 August 2010

Amoxy Active




Amoxy Active may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amoxy Active



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxy Active in the following countries:


  • Netherlands

International Drug Name Search

Nizale




Nizale may be available in the countries listed below.


Ingredient matches for Nizale



Ketoconazole

Ketoconazole is reported as an ingredient of Nizale in the following countries:


  • Portugal

International Drug Name Search

Monday, 9 August 2010

Alen-Far




Alen-Far may be available in the countries listed below.


Ingredient matches for Alen-Far



Alendronic Acid

Alendronic Acid is reported as an ingredient of Alen-Far in the following countries:


  • Dominican Republic

International Drug Name Search

Sunday, 8 August 2010

Yube E




Yube E may be available in the countries listed below.


Ingredient matches for Yube E



Tocopherol, α-

Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Yube E in the following countries:


  • Japan

International Drug Name Search

Friday, 6 August 2010

Meronem




Meronem may be available in the countries listed below.


UK matches:

  • Meronem IV 500mg & 1g
  • Meronem IV 500mg & 1g (SPC)

Ingredient matches for Meronem



Meropenem

Meropenem is reported as an ingredient of Meronem in the following countries:


  • Bahrain

  • Bosnia & Herzegowina

  • Costa Rica

  • Cyprus

  • Dominican Republic

  • Egypt

  • El Salvador

  • Ghana

  • Guatemala

  • Honduras

  • India

  • Indonesia

  • Iraq

  • Ireland

  • Israel

  • Jordan

  • Kenya

  • Kuwait

  • Latvia

  • Lebanon

  • Libya

  • Luxembourg

  • Malawi

  • Malaysia

  • Mozambique

  • Nicaragua

  • Nigeria

  • Oman

  • Panama

  • Peru

  • Qatar

  • Saudi Arabia

  • Serbia

  • Spain

  • Sri Lanka

  • Sudan

  • Syria

  • Tanzania

  • Turkey

  • Uganda

  • United Arab Emirates

  • Yemen

  • Zambia

  • Zimbabwe

Meropenem trihydrate (a derivative of Meropenem) is reported as an ingredient of Meronem in the following countries:


  • Aruba

  • Bahamas

  • Bangladesh

  • Barbados

  • Belgium

  • Bermuda

  • Brazil

  • Chile

  • Colombia

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Ecuador

  • Estonia

  • Finland

  • France

  • Georgia

  • Germany

  • Greece

  • Haiti

  • Hong Kong

  • Hungary

  • Iceland

  • Indonesia

  • Jamaica

  • Lithuania

  • Malta

  • Netherlands

  • Netherlands Antilles

  • Norway

  • Philippines

  • Poland

  • Portugal

  • Romania

  • Russian Federation

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Sweden

  • Switzerland

  • Thailand

  • Trinidad & Tobago

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 4 August 2010

Cofamix Sulfadimidine




Cofamix Sulfadimidine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cofamix Sulfadimidine



Sulfadimidine

Sulfadimidine is reported as an ingredient of Cofamix Sulfadimidine in the following countries:


  • France

International Drug Name Search

Monday, 12 July 2010

Foston




Foston may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Foston



Toldimfos

Toldimfos sodium salt (a derivative of Toldimfos) is reported as an ingredient of Foston in the following countries:


  • United Kingdom

International Drug Name Search

Friday, 9 July 2010

Fortathrin




Fortathrin may be available in the countries listed below.


Ingredient matches for Fortathrin



Indometacin

Indometacin is reported as an ingredient of Fortathrin in the following countries:


  • Greece

International Drug Name Search

Wednesday, 7 July 2010

Meristrak




Meristrak may be available in the countries listed below.


Ingredient matches for Meristrak



Estriol

Estriol is reported as an ingredient of Meristrak in the following countries:


  • Japan

International Drug Name Search

Monday, 5 July 2010

Supositorio de Glicerina




Supositorio de Glicerina may be available in the countries listed below.


Ingredient matches for Supositorio de Glicerina



Glycerol

Glycerol is reported as an ingredient of Supositorio de Glicerina in the following countries:


  • Chile

  • Peru

International Drug Name Search

Friday, 25 June 2010

Salazopyrina




Salazopyrina may be available in the countries listed below.


Ingredient matches for Salazopyrina



Sulfasalazine

Sulfasalazine is reported as an ingredient of Salazopyrina in the following countries:


  • Spain

International Drug Name Search

Tuesday, 22 June 2010

Vandisul




Vandisul may be available in the countries listed below.


Ingredient matches for Vandisul



Disulfiram

Disulfiram is reported as an ingredient of Vandisul in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 16 June 2010

Pulmicort Nasal Aqua Orifarm




Pulmicort Nasal Aqua Orifarm may be available in the countries listed below.


Ingredient matches for Pulmicort Nasal Aqua Orifarm



Budesonide

Budesonide is reported as an ingredient of Pulmicort Nasal Aqua Orifarm in the following countries:


  • Denmark

International Drug Name Search

Panklav




Panklav may be available in the countries listed below.


Ingredient matches for Panklav



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Panklav in the following countries:


  • Russian Federation

  • Serbia

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Panklav in the following countries:


  • Russian Federation

International Drug Name Search

Monday, 14 June 2010

Horamine




Horamine may be available in the countries listed below.


Ingredient matches for Horamine



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Horamine in the following countries:


  • Ethiopia

International Drug Name Search

Thursday, 10 June 2010

Ultraxime




Ultraxime may be available in the countries listed below.


Ingredient matches for Ultraxime



Cefixime

Cefixime is reported as an ingredient of Ultraxime in the following countries:


  • Philippines

International Drug Name Search

Sunday, 6 June 2010

Youdix




Youdix may be available in the countries listed below.


Ingredient matches for Youdix



Nalidixic Acid

Nalidixic Acid is reported as an ingredient of Youdix in the following countries:


  • Japan

International Drug Name Search

Monday, 31 May 2010

Paracetamol Serra Pamies




Paracetamol Serra Pamies may be available in the countries listed below.


Ingredient matches for Paracetamol Serra Pamies



Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Serra Pamies in the following countries:


  • Spain

International Drug Name Search

Wednesday, 26 May 2010

Adrianol




Adrianol may be available in the countries listed below.


Ingredient matches for Adrianol



Phenylephrine

Phenylephrine is reported as an ingredient of Adrianol in the following countries:


  • Russian Federation

International Drug Name Search

Thursday, 20 May 2010

Ritemed Ceftriaxone




Ritemed Ceftriaxone may be available in the countries listed below.


Ingredient matches for Ritemed Ceftriaxone



Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Ritemed Ceftriaxone in the following countries:


  • Philippines

International Drug Name Search

Wednesday, 19 May 2010

Terramycin Prolongatum




Terramycin Prolongatum may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Terramycin Prolongatum



Oxytetracycline

Oxytetracycline dihydrate (a derivative of Oxytetracycline) is reported as an ingredient of Terramycin Prolongatum in the following countries:


  • Norway

International Drug Name Search

Monday, 10 May 2010

Beclofortil




Beclofortil may be available in the countries listed below.


Ingredient matches for Beclofortil



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Beclofortil in the following countries:


  • Venezuela

International Drug Name Search

Tuesday, 4 May 2010

Secretin




In the US, Secretin (secretin systemic) is a member of the drug class in vivo diagnostic biologicals and is used to treat Diagnosis and Investigation.

US matches:

  • Secretin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V04CK01

CAS registry number (Chemical Abstracts Service)

0001393-25-5

Therapeutic Categories

Diagnostic agent, pancreas function

Autacoid

Chemical Name

Secretin

Foreign Names

  • Secretinum (Latin)
  • Secretin (German)
  • Sécrétine (French)
  • Secretina (Spanish)

Generic Names

  • Secretin (OS: BAN, USAN, JAN)
  • Sécrétine (OS: DCF)
  • E 286 (IS: Eisai)
  • Hoe 069 (IS)
  • Hormoduodine (IS)
  • Secretin (PH: JP XIV)

Brand Names

  • ChiRhoStim
    ChiRhoClin, United States


  • Secreflo
    ChiRhoClin, United States


  • Secrelux
    Sanochemia, Germany

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 25 April 2010

Troxérutine RPG




Troxérutine RPG may be available in the countries listed below.


Ingredient matches for Troxérutine RPG



Troxerutin

Troxerutin is reported as an ingredient of Troxérutine RPG in the following countries:


  • France

International Drug Name Search

Friday, 23 April 2010

Adizem




Adizem may be available in the countries listed below.


UK matches:

  • Adizem-SR capsules
  • Adizem-SR tablets
  • Adizem-XL capsules
  • Adizem-SR capsules (SPC)
  • Adizem-SR tablets (SPC)
  • Adizem-XL capsules (SPC)

Ingredient matches for Adizem



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Adizem in the following countries:


  • Bahrain

  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 21 April 2010

Oxytocin Stricker




Oxytocin Stricker may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oxytocin Stricker



Oxytocin

Oxytocin is reported as an ingredient of Oxytocin Stricker in the following countries:


  • Switzerland

International Drug Name Search

Sunday, 18 April 2010

Norgalax




Norgalax may be available in the countries listed below.


UK matches:

  • Norgalax Enema
  • Norgalax (SPC)

Ingredient matches for Norgalax



Docusate

Docusate Sodium is reported as an ingredient of Norgalax in the following countries:


  • Belgium

  • France

  • Germany

  • Ireland

  • Luxembourg

  • Netherlands

  • Singapore

  • Switzerland

  • Tunisia

  • United Kingdom

Glycerol

Glycerol is reported as an ingredient of Norgalax in the following countries:


  • Germany

  • Netherlands

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 15 April 2010

Ortho Evra


Ortho Evra is a brand name of ethinyl estradiol/norelgestromin, approved by the FDA in the following formulation(s):


ORTHO EVRA (ethinyl estradiol; norelgestromin - film, extended release; transdermal)



  • Manufacturer: JANSSEN PHARMS

    Approval date: November 20, 2001

    Strength(s): 0.02MG/24HR;0.15MG/24HR [RLD]

Has a generic version of Ortho Evra been approved?


No. There is currently no therapeutically equivalent version of Ortho Evra available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ortho Evra. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
    Patent 5,876,746
    Issued: March 2, 1999
    Inventor(s): Jona; Janan & Audett; Jay & Singh; Noel
    Assignee(s): Cygnus, Inc.
    Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women via an adhesive matrix of a silicone and/or polyisobutylene.
    Patent expiration dates:

    • November 20, 2015
      ✓ 
      Patent use: PREVENTION OF OVULATION IN A WOMAN
      ✓ 
      Drug product




  • Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
    Patent 5,972,377
    Issued: October 26, 1999
    Inventor(s): Jona; Janan & Audett; Jay & Singh; Noel
    Assignee(s): Cygnus, Inc.
    Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women.
    Patent expiration dates:

    • June 7, 2015
      ✓ 
      Patent use: PREVENTION OF OVULATION IN A WOMAN



See also...

  • Ortho Evra Consumer Information (Drugs.com)
  • Ortho Evra Patch Consumer Information (Wolters Kluwer)
  • Ortho Evra Consumer Information (Cerner Multum)
  • Ortho Evra Advanced Consumer Information (Micromedex)
  • Norelgestromin/Ethinyl Estradiol Patch Consumer Information (Wolters Kluwer)
  • Ethinyl estradiol and norelgestromin Consumer Information (Cerner Multum)
  • Ethinyl estradiol and norelgestromin Transdermal Advanced Consumer Information (Micromedex)

Tuesday, 13 April 2010

Lorazepam L.CH.




Lorazepam L.CH. may be available in the countries listed below.


Ingredient matches for Lorazepam L.CH.



Lorazepam

Lorazepam is reported as an ingredient of Lorazepam L.CH. in the following countries:


  • Chile

International Drug Name Search

Bactoscrub




Bactoscrub may be available in the countries listed below.


Ingredient matches for Bactoscrub



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Bactoscrub in the following countries:


  • Israel

International Drug Name Search

Wednesday, 7 April 2010

Decafen




Decafen may be available in the countries listed below.


Ingredient matches for Decafen



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Decafen in the following countries:


  • Bangladesh

International Drug Name Search

Monday, 5 April 2010

Inquixol




Inquixol may be available in the countries listed below.


Ingredient matches for Inquixol



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Inquixol in the following countries:


  • Venezuela

International Drug Name Search

Friday, 2 April 2010

Metronidazol La Santé




Metronidazol La Santé may be available in the countries listed below.


Ingredient matches for Metronidazol La Santé



Metronidazole

Metronidazole is reported as an ingredient of Metronidazol La Santé in the following countries:


  • Colombia

International Drug Name Search

Thursday, 1 April 2010

Amadin




Amadin may be available in the countries listed below.


Ingredient matches for Amadin



Glimepiride

Glimepiride is reported as an ingredient of Amadin in the following countries:


  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

International Drug Name Search

Saturday, 27 March 2010

Nicergolina Ratiopharm




Nicergolina Ratiopharm may be available in the countries listed below.


Ingredient matches for Nicergolina Ratiopharm



Nicergoline

Nicergoline is reported as an ingredient of Nicergolina Ratiopharm in the following countries:


  • Italy

International Drug Name Search

Thursday, 25 March 2010

Erythromycin TC




Erythromycin TC may be available in the countries listed below.


Ingredient matches for Erythromycin TC



Erythromycin

Erythromycin is reported as an ingredient of Erythromycin TC in the following countries:


  • Lithuania

International Drug Name Search

Tuesday, 23 March 2010

Decoderm tri




Decoderm tri may be available in the countries listed below.


Ingredient matches for Decoderm tri



Fluprednidene

Fluprednidene 21-acetate (a derivative of Fluprednidene) is reported as an ingredient of Decoderm tri in the following countries:


  • Germany

Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Decoderm tri in the following countries:


  • Germany

International Drug Name Search

Monday, 22 March 2010

AteHexal comp




AteHexal comp may be available in the countries listed below.


Ingredient matches for AteHexal comp



Atenolol

Atenolol is reported as an ingredient of AteHexal comp in the following countries:


  • Germany

Chlortalidone

Chlortalidone is reported as an ingredient of AteHexal comp in the following countries:


  • Germany

International Drug Name Search

Sunday, 21 March 2010

Elpi




Elpi may be available in the countries listed below.


Ingredient matches for Elpi



Clofibrate

Clofibrate is reported as an ingredient of Elpi in the following countries:


  • Argentina

International Drug Name Search

Friday, 12 March 2010

Busiral




Busiral may be available in the countries listed below.


Ingredient matches for Busiral



Buspirone

Buspirone hydrochloride (a derivative of Buspirone) is reported as an ingredient of Busiral in the following countries:


  • Yemen

International Drug Name Search

Wednesday, 10 March 2010

C-Komplex




C-Komplex may be available in the countries listed below.


Ingredient matches for C-Komplex



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of C-Komplex in the following countries:


  • Argentina

International Drug Name Search

Monday, 8 March 2010

Novo 5-ASA




Novo 5-ASA may be available in the countries listed below.


Ingredient matches for Novo 5-ASA



Aminosalicylic Acid

Aminosalicylic Acid is reported as an ingredient of Novo 5-ASA in the following countries:


  • Canada

International Drug Name Search

Monday, 1 March 2010

Magensiumchlorid 0.5 molar B.Braun




Magensiumchlorid 0.5 molar B.Braun may be available in the countries listed below.


Ingredient matches for Magensiumchlorid 0.5 molar B.Braun



Magnesium Chloride

Magnesium Chloride hexahydrate (a derivative of Magnesium Chloride) is reported as an ingredient of Magensiumchlorid 0.5 molar B.Braun in the following countries:


  • Switzerland

International Drug Name Search

Wednesday, 24 February 2010

Stromiten




Stromiten may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Stromiten



Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Stromiten in the following countries:


  • France

Niclosamide

Niclosamide is reported as an ingredient of Stromiten in the following countries:


  • France

International Drug Name Search

Sunday, 21 February 2010

Histacalmine




Histacalmine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Histacalmine



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Histacalmine in the following countries:


  • France

Hydroxyzine

Hydroxyzine hydrochloride (a derivative of Hydroxyzine) is reported as an ingredient of Histacalmine in the following countries:


  • France

International Drug Name Search

Monday, 15 February 2010

belatacept Intravenous


bel-AT-a-sept


Intravenous route(Powder for Solution)

Increased risk for developing posttransplant lymphoproliferative disorder (PTLD), predominantly involving the CNS. Recipients without immunity to Epstein-Barr virus (EBV) are at a particularly increased risk; therefore, use in EBV seropositive patients only. Do not use belatacept in transplant recipients who are EBV seronegative or with unknown EBV serostatus. Only physicians experienced in immunosuppressive therapy and management of kidney transplant patients should prescribe belatacept. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. Increased susceptibility to infection and the possible development of malignancies may result from immunosuppression. Use in liver transplant patients is not recommended due to an increased risk of graft loss and death



Commonly used brand name(s)

In the U.S.


  • Nulojix

Available Dosage Forms:


  • Powder for Solution

Uses For belatacept


Belatacept injection belongs to a group of medicines known as immunosuppressive agents. It is used together with other medicines to prevent the body from rejecting a transplanted kidney.


When a patient receives a kidney transplant, the body's white blood cells will try to get rid of (reject) the transplanted kidney. Belatacept works by suppressing the immune system and prevents the white blood cells from trying to get rid of the transplanted organ.


belatacept is to be given only by or under the direct supervision of a doctor.


Before Using belatacept


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For belatacept, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to belatacept or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of belatacept injection in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of belatacept injection in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of belatacept. Make sure you tell your doctor if you have any other medical problems, especially:


  • Cytomegalovirus (CMV) infection—Use with caution. May increase risk for more serious side effects.

  • Infection (e.g., bacteria, fungus, virus, or protozoa)—May decrease your body's ability to fight infection.

  • Tuberculosis infection—Should be treated before starting therapy with belatacept.

Proper Use of belatacept


A nurse or other trained health professional will give you belatacept in a hospital. belatacept is given through a needle placed in one of your veins. The medicine must be injected slowly, so the needle will need to stay in place for at least 30 minutes.


belatacept comes with a Medication Guide. It is very important that you read and understand this information. Be sure to ask your doctor about anything you do not understand.


Precautions While Using belatacept


It is very important that your doctor check your progress at regular visits to make sure that belatacept is working properly. Blood and urine tests may be needed to check for unwanted effects. Be sure to keep all appointments.


It is important to tell your doctor if you become pregnant. Your doctor may want you to join a pregnancy registry for patients using belatacept.


Do not receive belatacept if your doctor says you are Epstein-Barr virus (EBV) negative. Your doctor will test you for EBV.


Using belatacept may increase your risk of having serious conditions called post-transplant lymphoproliferative disorder (PTLD) or progressive multifocal leukoencephalopathy. The risk of developing PTLD is higher in patients who are EBV negative, have cytomegalovirus (CMV) infection, or have received treatments for transplant rejections. Check with your doctor right away if you have changes in mood or usual behavior, confusion, problems with thinking, loss of memory, decreased strength on one side of the body, or changes in vision, walking, or talking.


belatacept may increase your risk of getting certain types of cancer, especially of the skin. Talk to your doctor if you have concerns about this risk.


Use sunscreen or sunblock lotions with a sun protection factor (SPF) of at least 15 on a regular basis when you are outdoors. Wear protective clothing and hats, and stay out of direct sunlight between the hours of 10 a.m. and 3 p.m. Avoid sunlamps and tanning beds.


belatacept may increase your risk of developing infections. Avoid being near people who are sick or have infections while you are using belatacept. Wash your hands often. Tell your doctor if you have any kind of infection before you start using belatacept. Also tell your doctor if you have ever had an infection that would not go away or an infection that kept coming back.


You will need to have a skin test for tuberculosis before you start using belatacept. Tell your doctor if you or anyone in your home has ever had a positive reaction to a tuberculosis skin test.


belatacept may increase your risk for developing a rare and serious virus infection called polyoma virus-associated nephropathy (PVAN). PVAN is caused by BK virus. The BK virus may affect how your kidneys work and cause a transplanted kidney to fail. Check with your doctor right away if you are having more than one of these symptoms: bloody urine; a decreased frequency or amount of urine; increased thirst; loss of appetite; lower back or side pain; nausea; swelling of the face, fingers, or lower legs; trouble with breathing; unusual tiredness or weakness; vomiting; or weight gain.


While you are being treated with belatacept, and after you stop using it, it is important to talk to your doctor about the immunizations (vaccines) you should receive. Do not get any vaccine without your doctor's approval. Belatacept may lower your body's resistance and there is a chance you might get the infection the vaccine is meant to prevent. In addition, other persons living in your household should not receive certain vaccines since there is a chance they could pass the infection on to you. Talk to your doctor if you have questions about this.


belatacept Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Abdominal or stomach pain

  • agitation

  • black, tarry stools

  • bladder pain

  • bloating or swelling of the face, arms, hands, lower legs, or feet

  • bloody or cloudy urine

  • blurred vision

  • bone pain

  • burning while urinating

  • chest pain

  • chills

  • coma

  • confusion

  • convulsions

  • cough or hoarseness

  • decreased frequency or amount of urine

  • decreased urine output

  • depression

  • difficult or labored breathing

  • difficult, burning, or painful urination

  • dizziness

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • drowsiness

  • dry mouth

  • fainting

  • fast or irregular heartbeat

  • fever

  • frequent urge to urinate

  • headache

  • hostility

  • inability to move the arms and legs

  • increased blood pressure

  • increased thirst

  • irritability

  • itching in other skin areas

  • lethargy

  • loss of appetite

  • loss of bladder control

  • lower back or side pain

  • mood or mental changes

  • muscle pain or cramps

  • muscle spasms (tetany) or twitching

  • nausea or vomiting

  • nervousness

  • numbness or tingling in the hands, feet, or lips

  • pale skin

  • pounding in the ears

  • rapid weight gain

  • scaling

  • shortness of breath

  • slow or fast heartbeat

  • sore throat

  • sores, ulcers, or white spots on the lips or in the mouth

  • stupor

  • sudden decrease in the amount of urine

  • sudden numbness and weakness in the arms and legs

  • sweating

  • swelling of the face, ankles, or hands

  • swollen glands

  • tightness in the chest

  • trembling

  • troubled breathing

  • troubled breathing with exertion

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • unusual weight gain or loss

  • weakness or heaviness of the legs

  • weight gain

  • wheezing

Less common
  • Back pain

  • coughing or spitting up blood

  • drowsiness

  • joint pain, stiffness, or swelling

  • loss of appetite

  • night sweats

  • persistent non-healing sore

  • pink growth reddish patch or irritated area

  • shiny bump

  • sudden high fever or low-grade fever for months

  • swelling of the feet or lower legs

  • weight gain

  • white, yellow, or waxy scar-like area

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Abdominal or stomach cramps

  • blemishes on the skin

  • body aches or pain

  • collection of blood under the skin

  • cough producing mucus

  • deep, dark purple bruise

  • diarrhea

  • difficulty having a bowel movement (stool)

  • difficulty with moving

  • dry mouth

  • ear congestion

  • flushed, dry skin

  • fruit-like breath odor

  • hair loss or thinning of the hair

  • increased hunger

  • increased sweating

  • increased urination

  • itching, pain, redness, or swelling

  • loss of consciousness

  • loss of voice

  • muscle cramps in the hands, arms, feet, legs, or face

  • muscle or bone pain

  • muscle pain or stiffness

  • numbness and tingling around the mouth, fingertips, or feet

  • pain in the joints

  • pimples

  • shakiness in the legs, arms, hands, or feet

  • shortness of breath

  • sleeplessness

  • sneezing

  • swelling or inflammation of the mouth

  • tightness in the chest

  • tremor

  • trouble sleeping

  • unable to sleep

  • unexplained weight loss

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: belatacept Intravenous side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More belatacept Intravenous resources


  • Belatacept Intravenous Side Effects (in more detail)
  • Belatacept Intravenous Use in Pregnancy & Breastfeeding
  • Belatacept Intravenous Drug Interactions
  • Belatacept Intravenous Support Group
  • 0 Reviews for Belatacept Intravenous - Add your own review/rating


Compare belatacept Intravenous with other medications


  • Rejection Prophylaxis